logo

How is the development of new gout treatments progressing in 2024?

Hello! 👋 Are you curious about the latest news on gout treatment? Recent research and new drug development for gout are really progressing actively. Today, let's take a look at the current status of new gout medication development in 2024.

 

In recent years, there have been many advancements in gout medication research. While existing drugs are effective, they have side effects or limitations for long-term treatment. Therefore, new drugs are continuously being developed.

 

How is the development of new gout treatments progressing in 2024?

 

Currently, JW Pharmaceutical is developing the gout treatment EpiminuRad! The initial results of the multinational Phase 3 clinical trial have been viewed positively, and it has been recommended to continue the clinical trials.

 

Epapaminurad, developed as an oral medication, is a uric acid excretion promoter that selectively inhibits hURAT1. It is a promising new drug candidate effective for hyperuricemia and gout diseases with abnormally high uric acid levels in the blood.

 

통풍신약 임상 대만서 반려됐는데…JW중외 "괜찮다" 이유는 - 머니투데이

 

I hope we can accelerate the development of new global gout medications :)

0
0
Comments 3
  • Profile Image
    간식킬러
    오호 글로벌 통풍 신약 개발이 빠르게 진행되고 있다니, 좋은 소식이네요!
    에피미뉴라드 통풍치료제가 먹는 약이라서 더 좋은 거 같아요!
  • Profile Image
    원희
    내년 12월이 임상 종료 예정이네요
    신약 개발이 성공하면 좋겠네요
  • Profile Image
    불백맘마
    그래도 임상 실험이 생각보다 많이 진행됐네요!
    정말 현실적으로 먹는 약으로 통풍 치료제가 더 개발되면 좋겠어요!!